39 related articles for article (PubMed ID: 34783112)
21. Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome.
Wang J; Fröhlich H; Torres FB; Silva RL; Poschet G; Agarwal A; Rappold GA
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165191
[TBL] [Abstract][Full Text] [Related]
22. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
[TBL] [Abstract][Full Text] [Related]
23. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
24. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
25. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
[TBL] [Abstract][Full Text] [Related]
27. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
28. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
30. Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.
Liu XM; Du SL; Miao R; Wang LF; Zhong JC
Heart Fail Rev; 2022 Jan; 27(1):345-355. PubMed ID: 32648149
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
